PITTSBURGH (KDKA) -- For type 2 diabetes, how about a shot that's just once a week? The FDA is considering a medicine that would be a weekly shot. And it's not insulin. It's a hormone called albiglutide -- to be marketed by Glaxo Smith Kline as Eperzan. "It lowers blood glucose...
Unfortunately, semaglutide now must be given in weekly injections, which is tough on many patients, researchers said. Studies suggest that only 39% to 67% of type 2 diabetics keep up with their weekly semaglutide injections for a year, researchers said. Only 40% of patients ...
PITTSBURGH (KDKA) -- For type 2 diabetes, how about a shot that's just once a week?The FDA is considering a medicine that would be a weekly shot. And it's not insulin.It's a hormone called albiglutide -- to be marketed by Glaxo Smith Kline as Eperzan."It lowers blood glucose lev...